Mira Pharmaceuticals Inc [NASDAQ: MIRA] loss -4.83% on the last trading session, reaching $1.38 price per share at the time.
Mira Pharmaceuticals Inc represents 17.39 million in outstanding shares, while the company has a total market value of $26.32 million with the latest information. MIRA stock price has been found in the range of $1.36 to $1.47.
If compared to the average trading volume of 1.33M shares, MIRA reached a trading volume of 7955553 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Mira Pharmaceuticals Inc [MIRA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MIRA shares is $17.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MIRA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 42.10, with the Price to Cash per share for the same quarter was set at 0.04.
Trading performance analysis for MIRA stock
Mira Pharmaceuticals Inc [MIRA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by 0.00. With this latest performance, MIRA shares dropped by -6.12% in over the last four-week period, additionally plugging by 16.95% over the last 6 months – not to mention a rise of 21.05% in the past year of trading.
Mira Pharmaceuticals Inc (MIRA) Capital Structure & Debt Analysis
According to recent financial data for Mira Pharmaceuticals Inc. ( MIRA), the Return on Equity (ROE) stands at -556.87%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -399.86%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Mira Pharmaceuticals Inc’s Return on Invested Capital (ROIC) is -1362.63%, showcasing its effectiveness in deploying capital for earnings.
Mira Pharmaceuticals Inc (MIRA) Efficiency & Liquidity Metrics
Based on Mira Pharmaceuticals Inc’s (MIRA) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Mira Pharmaceuticals Inc (MIRA) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Mira Pharmaceuticals Inc. (MIRA) effectively leverages its workforce, generating an average of -$1554000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.79% and a Quick Ratio of 2.79%, indicating strong ability to cover short-term liabilities.
Mira Pharmaceuticals Inc [MIRA]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Mira Pharmaceuticals Inc posted -0.14/share EPS, while the average EPS was predicted by analysts to be reported at -0.15/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MIRA.
An analysis of Institutional ownership at Mira Pharmaceuticals Inc [MIRA]
There are presently around $5.06%, or 6.52%% of MIRA stock, in the hands of institutional investors. The top three institutional holders of MIRA stocks are: CROSS STAFF INVESTMENTS INC with ownership of 0.38 million shares, which is approximately 2.5939%. AVANTAX PLANNING PARTNERS, INC., holding 0.12 million shares of the stock with an approximate value of $$75644.0 in MIRA stocks shares; and AVANTAX PLANNING PARTNERS, INC., currently with $$25480.0 in MIRA stock with ownership which is approximately 0.2706%.
